Cargando…
A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor
Synovial Sarcoma (SS) is a rare soft-tissue malignancy. Only about 15% of SS originates from the retroperitoneum. Retroperitoneal SS (RSS) is usually diagnosed incidentally due to the anatomy of the retroperitoneum. The most common complaints of patients are abdominal and low back pain. Other common...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126900/ https://www.ncbi.nlm.nih.gov/pubmed/35634528 http://dx.doi.org/10.30476/IJMS.2021.90470.2141 |
_version_ | 1784712230978191360 |
---|---|
author | Ansari Djafari, Anahita Razzaghi, Mohammadreza Rakhshan, Azadeh Faraji, Saba Rahavian, Amir Hossein Hojjati, Seyyed Ali |
author_facet | Ansari Djafari, Anahita Razzaghi, Mohammadreza Rakhshan, Azadeh Faraji, Saba Rahavian, Amir Hossein Hojjati, Seyyed Ali |
author_sort | Ansari Djafari, Anahita |
collection | PubMed |
description | Synovial Sarcoma (SS) is a rare soft-tissue malignancy. Only about 15% of SS originates from the retroperitoneum. Retroperitoneal SS (RSS) is usually diagnosed incidentally due to the anatomy of the retroperitoneum. The most common complaints of patients are abdominal and low back pain. Other common symptoms of RSS are palpable abdominal mass, weight loss, and anemia. In this study, we will describe a 29-year-old white Asian man with a diagnosis of RSS after radical nephrectomy. He was admitted to the Urology Department of Shohada-e Tajrish hospital, Tehran, Iran in March 2019. The distinguishing feature of this case is the size of the mass, which has never been reported so much for retroperitoneal synovial sarcoma. Radiologic imaging showed a huge retroperitoneal mass originating from the kidney. Based on the pathologic features and immunohistochemistry (IHC) study, the diagnosis was consistent with synovial sarcoma. Accurate diagnosis of RSS is usually based on the pathological findings. Therefore, in case of doubt, a biopsy can be employed. Surgical resection of the tumor and lymph nodes dissection is the main and most important part of the treatment. Aggressive resection with free margin is recommended. The role of adjuvant and neoadjuvant chemotherapy in RSS is not certain to date, but it is recommended according to the patient’s condition. |
format | Online Article Text |
id | pubmed-9126900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Shiraz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-91269002022-05-26 A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor Ansari Djafari, Anahita Razzaghi, Mohammadreza Rakhshan, Azadeh Faraji, Saba Rahavian, Amir Hossein Hojjati, Seyyed Ali Iran J Med Sci Case Report Synovial Sarcoma (SS) is a rare soft-tissue malignancy. Only about 15% of SS originates from the retroperitoneum. Retroperitoneal SS (RSS) is usually diagnosed incidentally due to the anatomy of the retroperitoneum. The most common complaints of patients are abdominal and low back pain. Other common symptoms of RSS are palpable abdominal mass, weight loss, and anemia. In this study, we will describe a 29-year-old white Asian man with a diagnosis of RSS after radical nephrectomy. He was admitted to the Urology Department of Shohada-e Tajrish hospital, Tehran, Iran in March 2019. The distinguishing feature of this case is the size of the mass, which has never been reported so much for retroperitoneal synovial sarcoma. Radiologic imaging showed a huge retroperitoneal mass originating from the kidney. Based on the pathologic features and immunohistochemistry (IHC) study, the diagnosis was consistent with synovial sarcoma. Accurate diagnosis of RSS is usually based on the pathological findings. Therefore, in case of doubt, a biopsy can be employed. Surgical resection of the tumor and lymph nodes dissection is the main and most important part of the treatment. Aggressive resection with free margin is recommended. The role of adjuvant and neoadjuvant chemotherapy in RSS is not certain to date, but it is recommended according to the patient’s condition. Shiraz University of Medical Sciences 2022-05 /pmc/articles/PMC9126900/ /pubmed/35634528 http://dx.doi.org/10.30476/IJMS.2021.90470.2141 Text en Copyright: © Iranian Journal of Medical Sciences https://creativecommons.org/licenses/by-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ansari Djafari, Anahita Razzaghi, Mohammadreza Rakhshan, Azadeh Faraji, Saba Rahavian, Amir Hossein Hojjati, Seyyed Ali A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor |
title | A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor |
title_full | A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor |
title_fullStr | A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor |
title_full_unstemmed | A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor |
title_short | A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor |
title_sort | large primary retroperitoneal synovial sarcoma: a case report of a huge malignant tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126900/ https://www.ncbi.nlm.nih.gov/pubmed/35634528 http://dx.doi.org/10.30476/IJMS.2021.90470.2141 |
work_keys_str_mv | AT ansaridjafarianahita alargeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT razzaghimohammadreza alargeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT rakhshanazadeh alargeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT farajisaba alargeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT rahavianamirhossein alargeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT hojjatiseyyedali alargeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT ansaridjafarianahita largeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT razzaghimohammadreza largeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT rakhshanazadeh largeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT farajisaba largeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT rahavianamirhossein largeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor AT hojjatiseyyedali largeprimaryretroperitonealsynovialsarcomaacasereportofahugemalignanttumor |